Published Professional Work

  1. Polyomavirus-associated Prostatitis in Wistar Han Rats Following Immunosuppression in a Chronic Toxicity Study.

    Katherine Masek-Hammerman, Thomas P. Brown, Walter F. Bobrowski, Lindsay Thomlinson, Marie Debrue, Laurence Whiteley, and Zaher Radi. Toxicologic Pathology 2017, 45(5):589-592.

  2. Evaluation of miR-216A and miR-217 as potential biomarkers of acute exocrine pancreatic toxicity in rats.

    Jianying Wang, Wenhu Huang, Stephane Thibault, Thomas P. Brown, Walter Bobrowski, Hovhannes J. Gukasyan, Winston Evering, Wenyue Hu, Annette John-Baptiste, and Allison Vitsky. Toxicologic Pathology 2017, 45(2):321-334.

  3. The application of paraphenylenediamine staining for assessment of phospholipidosis.

    Norimitsu Shirai, Frank J. Geoly, Walter F. Bobrowski and Carlin Okerberg. Toxicologic Pathology 2016, 44(8), 1160-1165.

  4. Neurophysiological assessment of sympathetic cardiovascular activity after loss of postganglionic neurons in the anesthetized rat.

    Zahner MR, Liu CN, Okerberg CV, Opsahl AC, Bobrowski WF, Somps CJ. J. Pharmacol. Toxicol. Methods 2016, 80, 59-67.

  5. Characterization of a novel intestinal glycerol-3-phosphate acyltransferase pathway and its role in lipid homeostasis.

    I. Khatun, R. Clark, N. Vera, K. Kou, D. Erlon, T. Coskran, W. Bobrowski, C. Okerberg, B. Goodwin. Journal of Biological Chemistry 2016, 291, 2602.

  6. PF-1355, a mechanism-based myeloperoxidase inhibitor, prevents immune complex vasculitis and anti-glomerular basement membrane glomerulonephritis.

    Zheng W, Warner R, Ruggeri R, Su C, Cortes C, Skoura A, Ward J, Ahn K, Kalgutkar A, Sun D, Maurer TS, Bonin PD, Okerberg C, Bobrowski W, Kawabe T, Zhang Y, Coskran T, Bell S, Kapoor B, Johnson K, Buckbinder L. J. Pharmacol. Exp. Ther. 2015, 353(2), 288-98.

  7. Characterization, biomarkers, and reversibility of a monoclonal antibody-induced immune complex disease in cynomolgus monkeys (Macaca fascicularis).

    Heyen JR, Rojko J, Evans M, Brown TP, Bobrowski WF, Vitsky A, Dalton S, Tripathi N, Bollini SS, Johnson T, Lin JC, Khan N, Han B. Toxicologic Pathology 2014, 42(4), 765-734.

  8. Renal pathophysiologic role of cortical tubular inclusion bodies.

    Radi ZA, Stewart ZS, Grzemski FA, Bobrowski WF. Toxicologic Pathology 2013, 41(1), 32-37.

  9. Technical guide for nervous system sampling of the cynomolgus monkey for general toxicity studies.

    Pardo ID, Garman RH, Weber K, Bobrowski WF, Hardisty JF, Morton D. Toxicologic Pathology 2012, 40(4), 624-36.

  10. Ultrastructural localization of extracellular matrix proteins of the lymph node cortex: evidence supporting the reticular network as a pathway for lymphocyte migration.

    Gregg P. Sobocinski, Katherine Toy, Walter F. Bobrowski, Stephen Shaw, Arthur O. Anderson, and Eric P. Kaldjian. BMC Immunology 2010, 11:42.

  11. Cardiovascular Effects in Rats following Exposure to a Receptor Tyrosine Kinase Inhibitor.

    Shirley A. Aguirre, Jonathan R. Heyen, Walter Collette, III, Walter Bobrowski and Eileen R. Blasi. Toxicologic Pathology 2010, 38, 416-428.

  12. Human skin in organ culture and human skin cells (keratinocytes and fibroblasts) in monolayer culture for assessment of chemically induced skin damage.

    Varani J, Perone P, Spahlinger DM, Singer LM, Diegel KL, Bobrowski WF, and Dunstan R. Toxicologic Pathology 2007, 35(5), 693-701.

  13. An Immunohistochemical Approach to Differentiate Hepatic Lipidosis from Hepatic Phospholipidosis in Rats.

    Obert L, Sobocinski G, Bobrowski W, Metz A, Rolsma R, Altrogge D, and Dunstan R. Toxicologic Pathology 2007, 35(5), 728-34.

  14. Porcine Brain Microvessel Endothelial Cells (PBMEC) as an In Vitro Model to Predict In Vivo Blood-Brain Barrier (BBB) Permeability.

    Zhang Y, Li CSW, Ye Y, Johnson K, Poe J, Bobrowski W, Garrido R, and Madhu C. Drug Metabolism and Disposition, 2006, 34(11), 1935-43.

  15. Modeling inflammation-drug interactions in vitro: A rat Kupffer cell-hepatocyte coculture system.

    Tukov FF, Maddox JF, Amacher DE, Bobrowski WF, Roth RA, Ganey PE. Toxicology In Vitro 2006, 20(8), 1488-1499.

  16. Comparative Methods for Multiplex Analysis of Cytokine Protein Expression in Plasma of Lipopolysaccharide-Treated Mice.

    Bobrowski WF, McDuffie JE, Sobocinski G, Chupka J, Olle E, Bowman A, and Albassam M. Cytokine 2005, 32(5), 194-198.

  17. A stepwise method for the isolation of endothelial cells and smooth muscle cells from individual canine coronary arteries.

    Dame MK, Yu X, Garrido R, Bobrowski W, McDuffie JE, Murphy HS, Albassam M, Varani J. In Vitro Cell Dev. Biol.-Animal, 2003, 39(10), 402-406.

  18. Cytoskeletal protein degradation and neurodegeneration evolves differently in males and females following experimental head injury.

    Kupina NC, Detloff MR, Bobrowski WF, Snyder BJ, Hall ED. Exp. Neurol. 2003, 180(1), 55-73.

  19. Systemic proliferative changes and clinical signs in cynomolgus monkeys administered a recombinant derivative of human epidermal growth factor.

    Reindel JF, Gough AW, Pilcher GD, Bobrowski WF, Sobocinski GP, de la Iglesia FA. Toxicologic Pathology 2001, 29(2), 159-73.

  20. Spontaneously Occurring Hepatocellular Neoplasia in Adolescent Cynomolgus Monkeys (Macaca Fascicularis).

    Reindel JR, Walsh KM, Toy KA and Bobrowski WF. Vet. Pathol. 2000, 37, 656-662.

  21. Malignant Intracranial Teratoma in a Juvenile Wistar Rat.

    Reindel JR, Bobrowski WF, Gough AW and Anderson JA. Vet. Pathol. 1996, 33(4), 462-5.

  22. Transport properties are not altered across Caco-2 cells with heightened TEER despite underlying physiological and ultrastructural changes.

    Lu S, Gough AW, Bobrowski WF, and Stewart BH. J. Pharm. Sci. 1996, 85(3), 270-3.

  23. Morphogenesis of a zone-specific adrenocortical cytotoxicity in guinea pigs administered PD 132301-2, an inhibitor of acyl-CoA:cholesterol acyltransferase.

    Dominick MA, Bobrowski WF, MacDonald JR, Gough AW. Toxicologic Pathology 1993, 2(1), 54-62.

  24. Elemental studies in rat lens during galactose cataract reversal.

    Unakar NJ, Bobrowski WF, Tsui JY, Bagchi M, and Harding CV. Current Eye Research 1993, 12(7), 675-683.

  25. Subacute Toxicity of a Novel Inhibitor of Acyl-CoA: Cholesterol Acyltransferase in Beagle Dogs.

    Dominick MA, McGuire EJ, Reindel JF, Bobrowski WF, Bocan TM and Gough AW. Fundam. Appl. Toxicol. 1993; 20, 217-224.

  26. Alpha 2u-globulin nephropathy without nephrocarcinogenesis in male Wistar rats administered 1-(aminomethyl)cyclohexaneacetic acid.

    Dominick MA, Robertson DG, Bleavins MR, Sigler RE, Bobrowski WF, and Gough AW. Toxicol. Appl. Pharmacol. 1991, 111(3), 375-87.

  27. Proliferative exocrine pancreatic lesions in aged Wistar rats.

    Dominick MA, Bobrowski WF, and Metz AL. Toxicologic Pathology 1990, 18(3), 4236.

  28. Ultrastructural juxtaglomerular cell changes in normotensive rats treated with quinapril, an inhibitor of angiotensin-converting enzyme.

    Dominick MA, Bobrowski WF, Metz AL, Gough AW, and MacDonald JR. Toxicologic Pathology 1990, 18(3), 396406.

  29. Elemental and structural studies of the rat galactose cataract.

    Harding CV, Unakar NJ, Bagchi M, Chylack LT Jr, Jampel RS, Bobrowski WF, Dang L, Tsui JY, and Harding D. Lens Eye Toxic Research 1989, 6(3), 477501.

  30. A study of morphology and protein synthesis of mammalian ocular lenses maintained in organ culture.

    Bagchi M, Caporale MJ, Harding CV, and Bobrowski W. Lens Research 1987, 4, 5577.

  31. Elemental analysis of the developing rat galactose cataract.

    Harding CV, Unakar NJ, Bobrowski WF, Dang L, Tsui JY, and Harding D. Lens Research 1987, 4, 2754.

  32. Potassium distribution in the normal lens.

    Harding CV, Bobrowski WF, Dang L, Owczarzak MT, and Harding D. Lens Research 1986, 3, 36383.

  33. Electrolyte profiles in the anterior lens determined by microprobe analysis: Comparisons with other elements.

    Harding CV, Bobrowski WF, Susan SR, and Harding D. Lens Research 1985, 2, 36991.

  34. Elemental profiles in cryosections and frozen-dried bulk specimens of the normal lens.

    Harding CV, Susan SR, and Bobrowski WF. Ophthal. Res. 1984, 16, 276-83.

  35. Calcium-containing opacities in the human lens.

    Harding CV, Chylack LT Jr, Susan SR, Lo W-K, and Bobrowski WF. Invest. Ophthalmol. Vis. Sci. 1983, 24, 11941202.

  36. Elemental and ultrastructural analysis of specific human lens opacities.

    Harding CV, Chylack LT Jr, Susan SR, Lo W-K, and Bobrowski WF. Invest. Ophthalmol. Vis. Sci. 1982, 23, 1-13.